Neoadjuvant PSMA-RLT in Oligometastatic PCa

This study is testing a type of targeted radiation therapy called PSMA radioligand therapy (PSMA-RLT) as a treatment before the main surgery or radiation for prostate cancer that has spread to a small number of sites (called oligometastatic prostate cancer). **You may be eligible if...** - You have prostate cancer that has spread to a limited number of sites (up to 5 bone spots or up to 3 small lung spots), confirmed by a special PSMA scan - You are in good general health (ECOG score 0 or 1) - Your blood counts and kidney function meet minimum requirements - You are 75 years old or younger - You have not previously received hormone-blocking therapy (androgen deprivation therapy) **You may NOT be eligible if...** - You are participating in another interventional clinical trial - You have more than 5 bone metastases or spread to organs other than the lungs - You previously received androgen deprivation therapy - You have severe urinary problems or complete urinary blockage - You have serious psychiatric or medical conditions that would interfere with the study Talk to your doctor to see if this trial is right for you.